Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks

By sjmartinez • December 10, 2024

Yarava A, Marshall C, Reichert DE, Ye A, Khanal P, Robbins SH, Sachais BS, Oh D, Metcalf RA, Conry-Cantilena K, King K, Reyes M, Adamski J, Marques MB, Tran MH, Allen ES, Pach D, Blumberg N, Hobbs R, Nash T, Shenoy AG, Mosnaim GS, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Rausch W, Oei K, Abinante M, Forthal DN, Zand MS, Kassaye SG, Cachay ER, Gebo KA, Shoham S, Casadevall A, McBee NA, Amirault D, Wang Y, Hopkins E, Shade DM, Layendecker O, Klein SL, Park HS, Lee JS, Caturegli P, Raval JS, Cruser D, Ziman AF, Gerber J, Gniadek TJ, Bloch EM, Tobian AAR, Hanley DF, Sullivan DJ, Lane K; CSSC (COVID 19 Serologic Studies Consortium) group. Creating a plasma coordination center to support COVID-19 outpatient trials across a national network of hospital blood banks. J Clin Transl Sci. 2024 Nov 14;8(1):e200. doi: 10.1017/cts.2024.642. PMID: 39655012; PMCID: PMC11626586.

Tags: clinical trial management, cloud-based platform, convalescent plasma, covid-19, Decentralized clinical trial, Infectious Diseases, investigational drug services, Publications, supply chain management

Related Posts

Study design and procedures for a hybrid effectiveness-implementation incomplete stepped-wedge cluster-randomized trial to evaluate a differentiated point-of-care HIV diagnosis and management model for the prevention of vertical transmission of HIV in Malawi: The PAC-Man trial protocol

Herce ME, Cassidy C, Munson A, Edwards JK, Rutstein SE, Matoga M, Kumwenda C, Simon KR, van Oosterhout JJ, Cox CM, Kamanga F, Kumwenda W,[...]

Prevalence of chlamydial, gonococcal and syphilis positivity by anatomical site and sex via self-collected biospecimens using at-home testing kits among a large and diverse cohort of men and women enrolled in the MACS/WIHS Combined Cohort Study (MWCCS) in the USA

Mimiaga MJ, Tian J, Chiu I, Yonko EA, Noori G, Aziz N, Jamieson BD, Qian Y, Alcaide ML, Augenbraun M, Friedman MR, Kempf MC, Dionne-Odom[...]

Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort

Jayavelu ND, Qi J, Milliren CE, Ozonoff A, Liu S, Levy O, Baden LR, Melamed E, McComsey GA, Cairns CB, Schaenman J, Shaw AC, Hafler[...]